Ideal Marker for Targeted Axillary Dissection

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

January 1, 2023

Study Completion Date

May 30, 2023

Conditions
Breast Cancer
Interventions
PROCEDURE

Targeted axillary dissection

The surgical treatment procedure of targeted axillary dissection performed in patients in whom the pathological lymph nodes have been marked using the examined and compared markers (magnetic marker Magseed, iodine seed 125I, carbon suspension)

Trial Locations (5)

14700

Institute for the Care of Mother and Child, Prague, Czech Republic, Prague

65653

Masaryk Memorial Cancer Institute, Brno

70852

University Hospital Ostrava, Ostrava

74601

Silesian Hospital in Opava, Opava

76001

EUC Clinic in Zlín, Zlín

All Listed Sponsors
collaborator

Silesian Hospital in Opava

OTHER

collaborator

Masaryk Memorial Cancer Institute

OTHER

collaborator

EUC Clinic in Zlín

UNKNOWN

collaborator

Institute for the Care of Mother and Child, Prague, Czech Republic

OTHER

collaborator

University of Ostrava

OTHER

lead

University Hospital Ostrava

OTHER

NCT04580251 - Ideal Marker for Targeted Axillary Dissection | Biotech Hunter | Biotech Hunter